ArticleNanomedicine (London, England)2022

Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer.

Snehal K Shukla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.